Vor Biopharma Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
0.00 |
2.00 |
4.17 |
73.66 |
174.44 |
465.75 |
| Przychód Δ r/r |
0.00% |
inf% |
108.33% |
1667.74% |
136.84% |
166.99% |
| Przychód (min) |
0.00 |
2.00 |
4.17 |
73.66 |
174.44 |
465.75 |
| Przychód (max) |
0.00 |
2.00 |
4.17 |
73.66 |
174.44 |
465.75 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-96.65 |
-50.87 |
-32.44 |
-88.21 |
-2.06 |
5.50 |
| Zysk netto % |
-inf% |
-2543.28% |
-778.53% |
-119.76% |
-1.18% |
1.18% |
| EPS (średnia) |
-1.44 |
-0.74 |
-0.47 |
-0.92 |
-0.03 |
0.08 |
| Liczba analityków (Przychody) |
0 |
4 |
5 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
5 |
4 |
4 |
4 |
3 |
2 |
| symbol |
VOR |
VOR |
VOR |
VOR |
VOR |
VOR |